(Q39886835)

15 September 2017

title

Anti-tumor immunity in a model of acute myeloid leukemia (English)

1 reference

15 September 2017

Farzin Farzaneh

8

0 references

author name string

Adam T C Cheuk

1

1 reference

15 September 2017

James W Wells

2

1 reference

15 September 2017

Lucas Chan

3

1 reference

15 September 2017

Nigel B Westwood

4

1 reference

15 September 2017

Stuart A Berger

5

1 reference

15 September 2017

Hideo Yagita

6

1 reference

15 September 2017

Ko Okumura

7

1 reference

15 September 2017

Ghulam J Mufti

9

1 reference

15 September 2017

Barbara-Ann Guinn

10

1 reference

15 September 2017

publication date

1 March 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

50

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

447-454

1 reference

Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Immunotherapy of myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Simultaneous expression of different immunogenic antigens in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Therapeutic opportunities in the B7/CD28 family of ligands and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Role of 4-1BB:4-1BB ligand in cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Development of a whole cell vaccine for acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

c-KIT expression enhances the leukemogenic potential of 32D cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802653776

10.1080/10428190802653776

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference